PUBLIC COMPANY
save$SNYSanofi
Paris, FRupdated 3h ago
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89.
community read0 votes
pipeline
27
marketed
1
phase 3
9
catalysts ytd
5
approvals ytd
1
recalls ytd
0
Pipeline(27)
view full pipeline →pipeline depth27 products
1Preclinical2Phase 112Phase 29Phase 31Marketed2
comments(0)
5-min edit window · permanent after that